Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine).
D000328:Adult; D002389:Catatonia / Q000378:metabolism*; D003401:Creatine / Q000652:urine; D003545:Cysteine / Q000494:pharmacology*; D006801:Humans; D007210:Indoleacetic Acids / Q000652:urine; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000652:urine*; D010259:Paranoid Disorders / Q000378:metabolism*; D012559:Schizophrenia / Q000378:metabolism* / Q000652:urine*; D014191:Tranylcypromine / Q000494:pharmacology*; D014363:Tryptamines / Q000652:urine*; D014364:Tryptophan / Q000378:metabolism
D007210:Indoleacetic Acids; D014363:Tryptamines; D009536:Niacinamide; D014191:Tranylcypromine; D014364:Tryptophan; D003545:Cysteine; D003401:Creatine